Literature DB >> 32488498

Renal denervation improves vascular endothelial dysfunction by inducing autophagy via AMPK/mTOR signaling activation in a rat model of type 2 diabetes mellitus with insulin resistance.

Yong Wang1,2, Bikash Rijal1, Yunan An1, Mengping Xu3, Zhuqing Li4, Feng Zhang3, Chengzhi Lu5.   

Abstract

BACKGROUND: Recent clinical and animal studies have shown that renal denervation (RDN) improves insulin sensitivity and endothelial dysfunction. However, the specific mechanism remains incompletely understood. The purpose of this study is to investigate the effects of RDN on endothelial dysfunction of type 2 diabetes mellitus (T2DM) rat models with insulin resistance and to explore the underlying molecular mechanisms.
METHODS: Male Sprague-Dawley rats were fed with or without high-fat diet allocated in different groups, combined with low-dose streptozotocin which induces a rat model to develop T2DM with insulin resistance. RDN was conducted 1 week after the rat models fully developed T2DM. The animals were sub-divided into four groups randomly: control group (CON, n = 6), diabetic group (T2DM, n = 6), diabetic with sham surgery group (Sham, n = 6) and diabetic with RDN group (RDN, n = 6). Rats in all groups were studied at baseline, both preoperatively and 4 weeks after RDN, respectively. Western blot was used to detect the expression of angiotensin-converting enzyme 2 (ACE2) protein and the expression of autophagy-related proteins Beclin1, LC3 and p62 and autophagy signaling pathway AMPK/mTOR proteins and apoptosis-related protein caspase-3 in the aorta endothelial cells. In addition, the effects of ACE2 on autophagy of human umbilical vein insulin resistance endothelial cell culture in vitro were also studied.
RESULTS: RDN decreased plasma and renal tissue norepinephrine levels. The Von Willebrand factor level was also decreased, while the plasma level of nitric oxide (NO) was significantly increased after RDN. Compared with the T2DM group and the Sham group, the endothelium-dependent and endothelium-independent diastolic function of the RDN group was improved significantly, the expression of Beclin1, LC3, ACE2 and eNOS proteins was higher, and the level of p62 protein was decreased. Furthermore, we found that RDN can activate the expression of p-AMPK and inhibit the expression of p-mTOR. In cell culture experiment, ACE2 activated p-AMPK and inhibited p-mTOR, thus promoting autophagy.
CONCLUSIONS: RDN may not only increase the expression of ACE2 in the vascular endothelium, but also can via ACE2 activate p-AMPK and inhibit p-mTOR, thus promoting autophagy and improving endothelial dysfunction.

Entities:  

Keywords:  Angiotensin-converting enzyme 2; Autophagy; Endothelial dysfunction; Insulin resistance; Renal denervation; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2020        PMID: 32488498     DOI: 10.1007/s00592-020-01532-6

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  51 in total

Review 1.  Physiology in perspective: The Wisdom of the Body. Neural control of the kidney.

Authors:  Gerald F DiBona
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-09       Impact factor: 3.619

2.  Health care resource utilization and costs during episodes of care for type 2 diabetes mellitus-related comorbidities.

Authors:  S D Candrilli; J L Meyers; K Boye; J P Bae
Journal:  J Diabetes Complications       Date:  2014-12-24       Impact factor: 2.852

Review 3.  Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease.

Authors:  Giuseppe Mancia; Raffaella Dell'Oro; Fosca Quarti-Trevano; Francesco Scopelliti; Guido Grassi
Journal:  J Hypertens Suppl       Date:  2006-03

Review 4.  Role of renal sensory nerves in physiological and pathophysiological conditions.

Authors:  Ulla C Kopp
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-11-19       Impact factor: 3.619

5.  Sympathetic modulation of the renal glucose transporter GLUT2 in diabetic rats.

Authors:  Beatriz D'Agord Schaan; Maria Cláudia Irigoyen; Silvia Lacchini; Edson Dias Moreira; Helena Schmid; Ubiratan Fabres Machado
Journal:  Auton Neurosci       Date:  2005-01-15       Impact factor: 3.145

6.  Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension.

Authors:  Robert J Huggett; Eleanor M Scott; Stephen G Gilbey; John B Stoker; Alan F Mackintosh; David A S G Mary
Journal:  Circulation       Date:  2003-12-15       Impact factor: 29.690

7.  Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance.

Authors:  Simonetta Bacci; Sabrina Prudente; Massimiliano Copetti; Belinda Spoto; Stefano Rizza; Roberto Baratta; Natalia Di Pietro; Eleonora Morini; Rosa Di Paola; Alessandra Testa; Francesca Mallamaci; Giovanni Tripepi; Yuan-Yuan Zhang; Luana Mercuri; Sara Di Silvestre; Renato Lauro; Lorenzo Malatino; Agostino Consoli; Fabio Pellegrini; Assunta Pandolfi; Lucia Frittitta; Carmine Zoccali; Massimo Federici; Alessandro Doria; Vincenzo Trischitta
Journal:  Atherosclerosis       Date:  2012-10-16       Impact factor: 5.162

8.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

9.  Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005.

Authors:  Sarah Rosner Preis; Shih-Jen Hwang; Sean Coady; Michael J Pencina; Ralph B D'Agostino; Peter J Savage; Daniel Levy; Caroline S Fox
Journal:  Circulation       Date:  2009-03-23       Impact factor: 29.690

10.  Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting.

Authors:  Dipika Bansal; Kapil Gudala; Harini Muthyala; Hari Prasad Esam; Ramya Nayakallu; Anil Bhansali
Journal:  J Diabetes Investig       Date:  2014-04-02       Impact factor: 4.232

View more
  7 in total

1.  A novel palmitic acid hydroxy stearic acid (5-PAHSA) plays a neuroprotective role by inhibiting phosphorylation of the m-TOR-ULK1 pathway and regulating autophagy.

Authors:  Jian-Tao Wang; Zhong-Yu Yu; Ying-Hong Tao; Ying-Chao Liu; Yan-Mei Wang; Qi-Lin Guo; Jian-Zhong Xue; Xiao-Hong Wen; Qian Zhang; Xiao-Die Xu; Cheng-Feng He; Wen-Jiao Xue; Jing-Chun Guo; Hou-Guang Zhou
Journal:  CNS Neurosci Ther       Date:  2021-01-18       Impact factor: 5.243

2.  Acute renal denervation normalizes aortic function and decreases blood pressure in spontaneously hypertensive rats.

Authors:  Nathalia Juocys Dias Moreira; Fernando Dos Santos; Edson Dias Moreira; Daniela Farah; Leandro Eziquiel de Souza; Maikon Barbosa da Silva; Ivana Cinthya Moraes-Silva; Gisele Silvério Lincevicius; Elia Garcia Caldini; Maria Cláudia Costa Irigoyen
Journal:  Sci Rep       Date:  2020-12-11       Impact factor: 4.379

3.  The Physiological Role of Irisin in the Regulation of Muscle Glucose Homeostasis.

Authors:  Naohiro Yano; Yu Tina Zhao; Ting C Zhao
Journal:  Endocrines       Date:  2021-08-13

Review 4.  Mitophagy: A potential therapeutic target for insulin resistance.

Authors:  Peng Ning; Xiaobo Jiang; Jing Yang; Jiaxing Zhang; Fan Yang; Hongyi Cao
Journal:  Front Physiol       Date:  2022-08-23       Impact factor: 4.755

5.  Curcumin Blunts IL-6 Dependent Endothelial-to-Mesenchymal Transition to Alleviate Renal Allograft Fibrosis Through Autophagy Activation.

Authors:  Jiajun Zhou; Mengtian Yao; Minghui Zhu; Mengchao Li; Qiwei Ke; Bing Wu; Daming Wang
Journal:  Front Immunol       Date:  2021-05-28       Impact factor: 7.561

Review 6.  COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; M Alblihed; Susana G Guerreiro; Natália Cruz-Martins; Gaber El-Saber Batiha
Journal:  Front Cardiovasc Med       Date:  2021-05-20

7.  Maslinic acid activates renal AMPK/SIRT1 signaling pathway and protects against diabetic nephropathy in mice.

Authors:  Huijuan Gao; Hong Wu
Journal:  BMC Endocr Disord       Date:  2022-01-18       Impact factor: 2.763

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.